Article Text

PDF
Takayasu arteritis: challenges in diagnosis and management
  1. Esther S H Kim,
  2. Joshua Beckman
  1. Cardiovascular Division, Vanderbilt University Medical Center, Nashville, Tennessee, USA
  1. Correspondence to Dr Joshua Beckman, Vanderbilt University Medical Center, Heart and Vascular Institute, 1215 Ave South Medical Center East, 5th Floor, South Tower, Nashville, TN 37232-8802, USA; joshua.a.beckman{at}vanderbilt.edu

Abstract

Takayasu arteritis (TA) is a rare disease affecting chiefly young women, although it can affect both men and women and persons of many different ethnicities. TA carries a high morbidity rate, but importantly, overall mortality has declined over time such that the 15-year survival rate has increased from 82.9% for patients diagnosed between 1957 and 1975 to 96.5% for those diagnosed from 1976 to 1990. Severity of presenting arterial complications and delay to diagnosis have also decreased over the past decade owing to advances in non-invasive diagnostic imaging and the development of medical therapies. Despite these advances, there still remain significant gaps in the diagnosis and management of these complex patients. These gaps encompass the basic, yet extremely complex, tasks of defining a universally accepted diagnostic criterion, accurate assessment of disease activity and development of clinically meaningful and accurate outcome measures to guide necessary clinical trials for the management of these complex patients.

  • aortitis

Statistics from Altmetric.com

Footnotes

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.